Anticholinergic drug use and mortality among residents of long-term care facilities: A prospective cohort study

Journal of Clinical Pharmacology

Volumn 51, Issue 2, 2011, Pages 256-263

  Kumpula, Eeva Katri ^a   Bell, J Simon ^a,b   Soini, Helena ^c   Pitkälä, Kaisu H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Health Centre   (Finland)

Author keywords

Central nervous system; epidemiology; geriatrics; pharmacoepidemiology; psychopharmacology

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGE; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG FATALITY; DRUG USE; FEMALE; FINLAND; HAZARD RATIO; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PROSPECTIVE STUDY; SEX;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHOLINERGIC ANTAGONISTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; LONG-TERM CARE; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 79551714673     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010368410     Document Type: Article

References (53)

1. Tune L., Carr S., Hoag E., Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry. 1992 ; 149: 1393-1394.
2. Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008 ; 56: 1333-1341.
3. Roe CM, Anderson MJ, Spivack B. Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc. 2002 ; 50: 836-842.
4. Nishtala PS, Fois RA, McLachlan AJ, et al. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J Clin Pharmacol. 2009 ; 49: 1176-1184.
5. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medication in older people. Arch Intern Med. 2007 ; 167: 781-787.
6. Lechevallier-Michel N., Molimard M., Dartigues JF, Fabrigoule C., Fourrier-Réglat A. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005 ; 52: 143-151.
7. Ancelin ML, Artero S., Portet F., et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006 ; 332: 455-459.
8. Han L., McCusker J., Cole M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001 ; 161: 1099-1105.
9. Anstey KJ, Cherbuin N., Christensen H., et al. Follow-up of mild cognitive impairment and related disorders over four years in adults in their sixties: the PATH Through Life Study. Dement Geriatr Cogn Disord. 2008 ; 26: 226-233.
10. Bottiggi KA, Salazar JC, Yu L., et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry. 2006 ; 14: 980-984.
11. Chew ML, Mulsant BH, Pollock BG Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psychiatry. 2005 ; 13: 535-538.
12. Nebes RD, Pollock BG, Meltzer CC, et al. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology. 2005 ; 65: 1487-1489.
13. Aizenberg D., Sigler M., Weizman A., Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr. 2002 ; 14: 307-310.
14. Cancelli I., Gigli GL, Piani A., et al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol. 2008 ; 28: 654-659.
15. Landi F., Russo A., Liperoti R., et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007 ; 81: 235-241.
16. Panula J., Puustinen J., Jaatinen P., et al. Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study. Drugs Aging. 2009 ; 26: 963-971.
17. Han L., Agostini JV, Allore HG Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008 ; 56: 2203-2210.
18. Lechevallier-Michel N., Gautier-Bertrand M., Alpérovitch A., et al. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol. 2005 ; 60: 813-819.
19. Low LF, Anstey KJ, Sachdev P. Use of medications with anticholinergic properties and cognitive function in a young-old community sample. Int J Geriatr Psychiatry. 2009 ; 24: 578-584.
20. Johnell K., Fastbom J., Rosen M., Leimanis A. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother. 2007 ; 41: 1243-1248.
21. Haider SI, Johnell K., Weitoft GR, Thorslund M., Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009 ; 57: 62-69.
22. Merchant RA, Li B., Yap KB, Ng TP Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons. Age Ageing. 2009 ; 35: 108-108.
23. Johnell K., Fastbom J. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients. Drugs Aging. 2008 ; 25: 871-877.
24. Minzenberg MJ, Poole JH, Benton C., Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry. 2004 ; 161: 116-124. 25. Hajjar ER, Cafiero AC, Hanlon JT Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007 ; 5: 345-351.
25. Carnahan RM, Lund BC, Perry PJ, Culp KR, Pollock BG The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Psychopharmacol Bull. 2002 ; 36: 14-19.
26. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006 ; 46: 1481-1486.
27. Lu CJ, Tune LE Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry. 2003 ; 11: 458-461.
28. Uusvaara J., Pitkälä KH, Tienari PJ, et al. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc. 2009 ; 57: 427-431.
29. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE The anticholinergic risk scale and anticholinergic adverse effects in older people. Arch Intern Med. 2008 ; 168: 508-513.
30. Taipale HT, Bell JS, Soini H., Pitkälä KH Sedative load and mortality among residents of long-term care facilities: a prospective cohort study. Drugs Aging. 2009 ; 26: 871-881.
31. Bell JS, Taipale HT, Soini H., Pitkälä KH Prognostic significance of the quality indicator "concurrent use of three or more psychotropic drugs" among residents of long-term care facilities. Eur J Clin Pharmacol. 2009 ; 65: 1163-1164.
32. Suominen MH, Sandelin E., Soini H., Pitkala KH How well do nurses recognize malnutrition in elderly patients ? Eur J Clin Nutr. 2009 ; 63: 292-296.
33. Bell JS, Taipale HT, Soini H., Pitkälä KH Sedative load among long term care facility residents with and without dementia. Clin Drug Investig. 2010 ; 30: 63-70.
34. WHO Collaborating Centre for Drug Statistics Methodology. The Anatomical Therapeutic Chemical Classification System. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. http://www.whocc.no/atcddd/ Accessed January 29, 2010.
35. Charlson ME, Pompei P., Ales KL, MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and evaluation. J Chronic Dis. 1987 ; 40: 373-383.
36. Buntinx F., Niclaes L., Seutens C., et al. Evaluation of Charlson's comorbidity index in elderly living in nursing homes. J Clin Epidemiol. 2002 ; 55: 1144-1147.
37. Guigoz Y., Lauque S., Vellas BJ Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med. 2002 ; 18: 737-757.
38. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001 ; 49: 200-209.
39. Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry. 2007 ; 15: 416-424.
40. Hosia-Randell HM, Muurinen SM, Pitkälä KH Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008 ; 25: 683-692.
41. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003 ; 163: 2716-2724.
42. Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009 ; 26: 677-686.
43. Nishtala PS, McLachlan AJ, Bell JS, Chen TF Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry. 2008 ; 16: 621-632.
44. Magaziner J., Simonsick EM, Kashner TM, Hebel JR, Kenzora JE Survival experience of aged hip fracture patients. Am J Public Health. 1989 ; 79: 274-278.
45. Bass E., French DD, Bradham DD, Rubenstein LZ Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol. 2007 ; 17: 514-519.
46. Wang PS, Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 ; 353: 2335-2341.
47. Singh S., Loke YK, Furberg CD Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008 ; 300: 1439-1450.
48. Martikainen P., Moustgaard H., Murphy M., et al. Gender, living arrangements, and social circumstances as determinants of entry into and exit from long-term institutional care at older ages: a 6-year follow-up study of older Finns. Gerontologist. 2009 ; 49: 34-45.
49. Ganjavi H., Herrmann N., Rochon PA, et al. Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord. 2004 ; 23: 395-400.
50. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005 ; 294: 1934-1943.
51. Lau HS, de Boer A., Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997 ; 50: 619-625.
52. Hilmer SN, Abernethy DR Measures of drug toxicity in older adults. Arch Intern Med. 2008 ; 168: 1930-1931.
53. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009 ; 9: 5.